NMRA 241220 7.50P (NMRA241220P7500) Stock Options, News & Quotes

0.55
0.000.00%

15min DelayTrading Dec 3 11:04 ET

0.55High0.55Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Kevin Travers

Oct 21 15:18

Columns Nvidia and Apple Pull Nasdaq Higher with Records, Market Falls | Wall Street Today

The market fell Monday, but $NVIDIA (NVDA.US)$ and $Apple (AAPL.US)$ hit all-time highs. Investors will see some heavy hitter earnings this week, including Tesla on Wednesday, where investors will judge the EV firm's Q3 results.
Just after 4 pm, the $S&P 500 Index (.SPX.US)$ fell 18 basis points, the $Dow Inc (DOW.US)$ fell 0.80%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.27% on tech positivity.
MACRO
This...

Will Nvidia dethrone Apple as world's most valuable company?

Kevin Travers

Oct 21 11:09

Columns Monday Market Pulls Back From Highs, With Earnings To Come | Moovin Stonks

Good afternoon traders, happy Monday, October 21st, the start of a brand new week! Investors will see some heavy hitter earnings this week, including the first of the magnificent seven, Tesla reporting on Wednesday. The market is falling Monday, after hitting highs Thursday last week.
My name is Kevin Travers; here are the news stories and animal spirits hitting Wall Street Today.
$Spirit Airlines (SAVE.US)$ jumped more th...

Moomoo AI

Jan 22 06:02

Ms. Pai Panandiker's appointment, with her vast neuropsychiatry commercial expertise, is seen as invaluable for Neumora's potential commercialization of navacaprant and pipeline advancement. Her experience in neuroscience product commercialization is expected to boost Neumora's growth.

Press Release: Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

Moomoo AI

Dec 12, 2023 06:06

CEO of Neumora Therapeutics is optimistic over Mr. Duncan's appointment due to his legal expertise and program strategy, valuable to the company's goal of advancing neuroscience drug development. Duncan highlights Neumora's leading brain disorder pipeline and recent clinical progress.

Press Release: Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

Moomoo AI

Oct 10, 2023 06:54

CEO of Neumora, Henry Gosebruch, values Dr. Lenz's successful trial experience and neuroscience expertise for their pipeline development. Dr. Lenz is excited to contribute significantly to Neumora's R&D and neuropsychiatry programs.

Press Release: Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development